Cargando...
Patient-derived organoids as a predictive biomarker for treatment response in cancer patients
Effective predictive biomarkers are needed to enable personalized medicine and increase treatment efficacy and survival for cancer patients, thereby reducing toxic side effects and treatment costs. Patient-derived organoids (PDOs) enable individualized tumour response testing. Since 2018, 17 publica...
Gardado en:
| Publicado en: | NPJ Precis Oncol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Nature Publishing Group UK
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8042051/ https://ncbi.nlm.nih.gov/pubmed/33846504 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41698-021-00168-1 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|